These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6123832)

  • 21. [Immunotherapy for type 1 diabetes mellitus (DM1)].
    van der Torren CR; Roep BO
    Ned Tijdschr Geneeskd; 2012; 156(15):A4268. PubMed ID: 22495007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy in type 1 diabetes.
    Pozzilli P
    Diabet Med; 1988 Nov; 5(8):734-8. PubMed ID: 2975564
    [No Abstract]   [Full Text] [Related]  

  • 23. Specific therapeutic attempts in experimental and clinical type-I diabetes.
    Federlin K; Becker F
    Klin Wochenschr; 1990; 68 Suppl 21():38-43. PubMed ID: 2198389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tackling type 1 diabetes: new immune-modulating drugs attack the root cause.
    Shekhar C
    Chem Biol; 2007 Dec; 14(12):1305-6. PubMed ID: 18096495
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunotherapies currently in development for the treatment of type 1 diabetes.
    Davis IC; Randell J; Davis SN
    Expert Opin Investig Drugs; 2015; 24(10):1331-41. PubMed ID: 26364507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can insulin therapy delay or prevent insulin-dependent diabetes mellitus?
    Kakka R; Koda-Kimble MA
    Pharmacotherapy; 1997; 17(1):38-44. PubMed ID: 9017764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunosuppression trials in type I diabetes].
    Feutren G; Boitard C; Assan R; Bach JF
    Journ Annu Diabetol Hotel Dieu; 1987; ():147-69. PubMed ID: 3302472
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunotherapy of type 1 diabetes--how to rationally prioritize combination therapies in T1D.
    Boettler T; von Herrath M
    Int Immunopharmacol; 2010 Dec; 10(12):1491-5. PubMed ID: 20667487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy in type 1 diabetes: present status.
    Pozzilli P; Kolb H
    Immunol Today; 1989 Oct; 10(10):321-2. PubMed ID: 2679628
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of diabetes with encapsulated pig islets: an update on current developments.
    Zhu HT; Lu L; Liu XY; Yu L; Lyu Y; Wang B
    J Zhejiang Univ Sci B; 2015 May; 16(5):329-43. PubMed ID: 25990050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunointervention in type 1 diabetes mellitus].
    Vialettes B
    Diabete Metab; 1992; 18(1):3-10; discussion 11-3. PubMed ID: 1563533
    [No Abstract]   [Full Text] [Related]  

  • 32. Update on global intervention studies in type 1 diabetes.
    Chiang JL; Haller MJ; Schatz DA
    Endocrinol Metab Clin North Am; 2012 Dec; 41(4):695-712. PubMed ID: 23099265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type I insulin dependent diabetes: an autoimmune disease that can be arrested or prevented with immunotherapy?
    Winter WE; Maclaren NK
    Adv Pediatr; 1985; 32():159-75. PubMed ID: 3909773
    [No Abstract]   [Full Text] [Related]  

  • 34. For parents. Type 1 diabetes research. Balancing hope with realism.
    Dinsmoor RS
    Diabetes Self Manag; 2003; 20(2):87-8, 91-2, 95, 99-102. PubMed ID: 12715738
    [No Abstract]   [Full Text] [Related]  

  • 35. Organ transplantation in diabetics. Synopsis of the 1983 symposium.
    Van Schilfgaarde R
    Neth J Med; 1985; 28(6):246-53. PubMed ID: 3925354
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunosuppressive therapy in type 1 diabetes: update].
    Pozzilli P
    Recenti Prog Med; 1987 Nov; 78(11):514-6. PubMed ID: 3324237
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current state of the problem of allotransplantation of Langerhans cells (achievements and prospects)].
    Alekberzade AV; Krylov NN; Adzhun Z; Laftavi MR; Shakhbazov RO; Zuykova KS
    Khirurgiia (Mosk); 2018; (11):80-88. PubMed ID: 30531761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.
    Eldor R; Cohen IR; Raz I
    Int Rev Immunol; 2005; 24(5-6):327-39. PubMed ID: 16318985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary prevention of type 1 diabetes mellitus: stopping immune destruction and promoting beta-cell regeneration.
    Couri CE; Foss MC; Voltarelli JC
    Braz J Med Biol Res; 2006 Oct; 39(10):1271-80. PubMed ID: 16941054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous hematopoietic stem cell transplantation in type 1-diabetes.
    Rosengren AH; Renström E
    Islets; 2009; 1(1):81-3. PubMed ID: 21084854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.